1. Home
  2. SVM vs VIR Comparison

SVM vs VIR Comparison

Compare SVM & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SVM

Silvercorp Metals Inc.

HOLD

Current Price

$8.64

Market Cap

1.4B

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$5.75

Market Cap

773.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SVM
VIR
Founded
N/A
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
773.5M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SVM
VIR
Price
$8.64
$5.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
11
Target Price
$9.00
$25.73
AVG Volume (30 Days)
5.8M
2.0M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
0.30%
N/A
EPS Growth
N/A
N/A
EPS
0.12
N/A
Revenue
$323,391,000.00
$16,860,000.00
Revenue This Year
$22.28
N/A
Revenue Next Year
$32.53
$48.05
P/E Ratio
$73.26
N/A
Revenue Growth
33.99
N/A
52 Week Low
$2.87
$4.16
52 Week High
$8.95
$14.45

Technical Indicators

Market Signals
Indicator
SVM
VIR
Relative Strength Index (RSI) 66.73 42.12
Support Level $8.43 $6.49
Resistance Level $8.95 $6.75
Average True Range (ATR) 0.43 0.48
MACD 0.03 -0.09
Stochastic Oscillator 77.46 18.63

Price Performance

Historical Comparison
SVM
VIR

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: